BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF 26.60
-0.80 (-2.92%)
At close: Jul 31, 2026
BioVersys AG Market Cap
BioVersys AG has a market cap or net worth of 155.73 million as of July 31, 2026. Its market cap has decreased by -20.88% in one year.
Market Cap
155.73M
Enterprise Value
94.96M
Revenue
3.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.60
ChartMarket Cap Chart
Since February 6, 2025, BioVersys AG's market cap has decreased from 207.92M to 155.73M, a decrease of -25.10%. That is a compound annual growth rate of -17.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 155.73M | 9.14% |
| Dec 30, 2025 | 142.69M | -31.37% |
| Feb 6, 2025 | 207.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.61B |
| Idorsia | 1.61B |
| Basilea Pharmaceutica AG | 643.35M |
| Newron Pharmaceuticals | 242.60M |
| Santhera Pharmaceuticals Holding AG | 212.07M |
| Molecular Partners AG | 124.91M |
| Xlife Sciences AG | 96.08M |
| MindMaze Therapeutics Holding | 30.40M |